These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30147013)

  • 21. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
    Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
    Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
    Parte SC; Batra SK; Kakar SS
    J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 as biomarker for radioresistant cancer stem cells.
    Trautmann F; Cojoc M; Kurth I; Melin N; Bouchez LC; Dubrovska A; Peitzsch C
    Int J Radiat Biol; 2014 Aug; 90(8):687-99. PubMed ID: 24650104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin α6 (CD49f), The Microenvironment and Cancer Stem Cells.
    Bigoni-Ordóñez GD; Czarnowski D; Parsons T; Madlambayan GJ; Villa-Diaz LG
    Curr Stem Cell Res Ther; 2019; 14(5):428-436. PubMed ID: 30280675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
    Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
    BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
    de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
    J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
    Melzer C; von der Ohe J; Lehnert H; Ungefroren H; Hass R
    Mol Cancer; 2017 Feb; 16(1):28. PubMed ID: 28148265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
    Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
    Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.
    Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
    Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance.
    Brown Y; Hua S; Tanwar PS
    Int J Biochem Cell Biol; 2019 Apr; 109():90-104. PubMed ID: 30743057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
    Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
    Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.
    Wang H; Yang M; Lin L; Ren H; Lin C; Lin S; Shen G; Ji B; Meng C
    Cell Oncol (Dordr); 2016 Feb; 39(1):35-45. PubMed ID: 26650484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.